ONIVYDE PEGYLATED LIPOSOMAL
Concentrate for dispersion for infusion, 4.3mg/ml
RxActive license
Active substance (INN)
irinotecan
Pharmaceutical form
Pharmaceutical formConcentrate for dispersion for infusion
Strength4.3mg/ml
PackagingUkupno 1 bočica staklena sa 10ml koncentrata za disperziju za infuziju u kartonskoj kutiji
ManufacturerLes Laboratoires Servier Industrie, France
Therapeutic groupAntineoplastic and immunomodulating agents (L01CE02)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateDecember 20, 2022
Analogs in Montenegro
7Other medicines with the same active substance
IRINOTECAN ACCORDRx
Concentrate for solution for infusion, 20mg/mlIRINOTECAN ACCORDRx
Concentrate for solution for infusion, 20mg/mlIRINOTECAN ACCORDRx
Concentrate for solution for infusion, 20mg/mlIRINOTECAN QILURx
Concentrate for solution for infusion, 40mg/2mlIRINOTECAN QILURx
Concentrate for solution for infusion, 100mg/5mlIRITECRx
Concentrate for solution for infusion, 100mg/5mlIRITECRx
Concentrate for solution for infusion, 40mg/2mlSource: CInMED register